The global biopsy devices market was valued at USD 2.25 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2030. This growth is being driven by several key factors, including the rising prevalence of cancer, an increasing emphasis on minimally invasive surgical techniques, the existence of untapped opportunities in emerging economies—particularly in the Asia Pacific region—and the overall improvement of healthcare infrastructure. These trends collectively contribute to the positive outlook for the industry.

According to the Union for International Cancer Control (UICC), the number of new cancer cases is expected to exceed 35 million by 2050, representing an alarming increase of about 77% from the estimated 20 million cases reported in 2022. This substantial rise in cancer incidence is anticipated to significantly boost the demand for biopsy devices, thereby fostering market expansion.

Additionally, the advantages associated with minimally invasive procedures have spurred their global adoption. These types of procedures offer patients quicker recovery times and are generally less traumatic compared to traditional surgical methods. The growing preference for minimally invasive techniques has also driven innovation within the market. A notable example occurred in July 2022, when medical professionals at NewYork-Presbyterian/Columbia unveiled a new technology that provides a safer, less invasive, and more timely approach to performing lung biopsies.

Gather more insights about the market drivers, restrains and growth of the Biopsy Devices Market

Product Insights

In 2023, needle-based biopsy guns held a dominant position in the market, capturing the largest share at 43.1%. This prevalence is largely attributed to the growing demand for these devices, which are essential for collecting samples from the soft tissues of internal organs. The efficiency and effectiveness of needle-based biopsy guns make them a preferred choice among healthcare professionals for various diagnostic procedures. As the healthcare landscape evolves, the need for accurate and minimally invasive sampling techniques continues to rise, propelling the growth of this market segment.

One of the critical factors driving the demand for needle-based biopsy guns is the increasing requirement for rapid and gentle procurement of cell samples. This necessity has led to significant advancements in biopsy technology, particularly with the introduction of innovative devices such as vacuum-assisted biopsy (VAB) systems. These systems enhance the precision and speed of sample collection, minimizing patient discomfort and maximizing the quality of the samples obtained. For example, in August 2022, Mammotome launched its Vacuum-Assisted Breast Biopsy System, designed specifically to facilitate lesion excision. This innovative technology exemplifies the trend toward developing more sophisticated biopsy devices, which is likely to further stimulate market growth.

In addition to needle-based biopsy guns, the biopsy needle segment is anticipated to experience considerable growth throughout the forecast period. This segment's expansion can be attributed to several factors, including technological advancements and an increasing demand for specialized needles that can effectively access challenging anatomical structures during biopsies. As healthcare practitioners aim to improve diagnostic accuracy, the ability to navigate complex anatomical areas becomes crucial. Innovations in biopsy needle design are playing a pivotal role in meeting these requirements, allowing for better accessibility and precision in sample collection.

The ongoing innovation in biopsy needle technology is expected to be a significant driver of segmental growth. For instance, in May 2024, Cook Medical introduced the EchoTip AcuCore EUS biopsy needle, specifically designed for precision biopsies of gastrointestinal lesions. This product's launch highlights the commitment of industry players to develop advanced solutions that address the evolving needs of medical professionals. Such innovations are essential in enhancing the accuracy and reliability of biopsy procedures, which, in turn, supports the broader market for biopsy devices.

Order a free sample PDF of the Biopsy Devices Market Intelligence Study, published by Grand View Research.